Clinical Trial Update: Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM [Phase 4]

View source ↗

Summary

Phase 4 trial assessing how chronic exenatide therapy influences beta cell function and insulin sensitivity in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2023-07-20